Prøve GULL - Gratis

'Deadly Risk' of Fat-Loss Drugs

Newsweek US

|

March 22, 2024

Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts

- PANDORA DEWAN

'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

FLERE HISTORIER FRA Newsweek US

Newsweek US

Newsweek US

THE DREAM OF PEACE

In an exclusive interview at his home, Israel's President Isaac Herzog tells Newsweek's editor-in-chief how he hopes to normalize his country's relations with Saudi Arabia... with the help of Donald Trump

time to read

7 mins

December 19, 2025

Newsweek US

Newsweek US

AMERICA'S MOST RESPONSIBLE COMPANIES 2026

FOR SOME CONSUMERS, what's important isn't just what a company offers but how they manufacture or provide those products or services.

time to read

3 mins

December 19, 2025

Newsweek US

Newsweek US

The Next Chapter

In Trump's shadow, JD Vance is quietly developing a plan to inherit the MAGA movement in 2028 and beyond

time to read

13 mins

December 19, 2025

Newsweek US

Newsweek US

WAGNER MOURA

The actor talks The Secret Agent, the Oscars buzz surrounding it and why “carrying Brazil with us” makes the moment so special

time to read

2 mins

December 19, 2025

Newsweek US

Newsweek US

WALKER SCOBELL

WALKER SCOBELL IS ACUTELY AWARE OF THE ANTICIPATION SURROUND-ing the second season of Disney+'s Percy Jackson and the Olympians (December 10).

time to read

1 mins

December 19, 2025

Newsweek US

Newsweek US

'YOUNG, DUMB AND FULL OF CHRIST'

Faith plays a starring role in Rian Johnson's new Knives Out film, Wake Up Dead Man

time to read

9 mins

December 19, 2025

Newsweek US

Newsweek US

IS THE SURROGACY BOOM ABOUT TO BURST?

Activists and lawmakers are joining forces to challenge paid pregnancy

time to read

9 mins

December 19, 2025

Newsweek US

Newsweek US

TV WIVES FLIP THE SCRIPT ON RELIGION

Heather Gay and the new face of Mormonism

time to read

6 mins

December 5, 2025

Newsweek US

Newsweek US

Hokuhoku Financial Group on Growth Beyond Borders

From Hokuriku Region and Japan's northern heartlands, Hokuhoku Financial Group, with Hokuriku Bank and Hokkaido Bank at its core, is driving regional renewal by uniting finance, technology, and community to spark sustainable growth across borders and generations.

time to read

5 mins

December 5, 2025

Newsweek US

Newsweek US

Power Shift

As governors emerge as the Democrats' top messengers, the trend of senators becoming the party's presidential nominee looks set to change in 2028

time to read

5 mins

December 5, 2025

Listen

Translate

Share

-
+

Change font size